These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
237 related items for PubMed ID: 16323984
1. Constitutive activation of the 41- and 43-kDa mitogen-activated protein (MAP) kinases in the progression of prostate cancer to an androgen-independent state. Oka H, Chatani Y, Kohno M, Kawakita M, Ogawa O. Int J Urol; 2005 Oct; 12(10):899-905. PubMed ID: 16323984 [Abstract] [Full Text] [Related]
11. Ghrelin and a novel preproghrelin isoform are highly expressed in prostate cancer and ghrelin activates mitogen-activated protein kinase in prostate cancer. Yeh AH, Jeffery PL, Duncan RP, Herington AC, Chopin LK. Clin Cancer Res; 2005 Dec 01; 11(23):8295-303. PubMed ID: 16322288 [Abstract] [Full Text] [Related]
13. Short hairpin RNA knockdown of the androgen receptor attenuates ligand-independent activation and delays tumor progression. Cheng H, Snoek R, Ghaidi F, Cox ME, Rennie PS. Cancer Res; 2006 Nov 01; 66(21):10613-20. PubMed ID: 17079486 [Abstract] [Full Text] [Related]
14. Guggulsterone-induced apoptosis in human prostate cancer cells is caused by reactive oxygen intermediate dependent activation of c-Jun NH2-terminal kinase. Singh SV, Choi S, Zeng Y, Hahm ER, Xiao D. Cancer Res; 2007 Aug 01; 67(15):7439-49. PubMed ID: 17671214 [Abstract] [Full Text] [Related]
18. The mitogen-activated protein kinase phosphatase vaccinia H1-related protein inhibits apoptosis in prostate cancer cells and is overexpressed in prostate cancer. Arnoldussen YJ, Lorenzo PI, Pretorius ME, Waehre H, Risberg B, Maelandsmo GM, Danielsen HE, Saatcioglu F. Cancer Res; 2008 Nov 15; 68(22):9255-64. PubMed ID: 19010898 [Abstract] [Full Text] [Related]